Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07821515
What this trial is testing

Does Paracetamol Influence the Release of Gut Hormones, Glucose Absorption and Glycemia?

Who this might be right for
Healthy Young AdultsPhysiology
University of Copenhagen 12
Not applicableStudy completedNCT03779321
What this trial is testing

Effect of Food Acceptability on Appetite Hormones' Response in Normal Weight vs. Obese Male Subjects

Who this might be right for
Eating Behavior
American University of Beirut Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT06500429
What this trial is testing

Evaluate the Safety and Efficacy of NG101 in Adult Participants Receiving a Glucagon-like Peptide-1 (GLP-1) Agonist

Who this might be right for
Overweight and ObesityHealthy
Neurogastrx, Inc. 120
Not applicableStudy completedNCT04108065
What this trial is testing

The Role of Pregnancy-induced Gallbladder Dysmotility in the Pathophysiology of Gestational Diabetes Mellitus

Who this might be right for
Gestational Diabetes Mellitus
University Hospital, Gentofte, Copenhagen 30
Not applicableStudy completedNCT05306613
What this trial is testing

Breaking Sitting and Metabolic Health in Sedentary Lean Adults

Who this might be right for
Metabolic HealthGut HormonesEnergy Balance
National Taiwan Normal University 13
Very early researchWithdrawnNCT04355832
What this trial is testing

Glucagon-like Peptide-1 in Type 1 Diabetes

Who this might be right for
Type1 Diabetes Mellitus
University of Maryland, Baltimore
Post-approval studies (Phase 4)Looking for participantsNCT07136714
What this trial is testing

Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity

Who this might be right for
Major Depressive Disorder
Nordsjaellands Hospital 116
Large-scale testing (Phase 3)Study completedNCT00715624
What this trial is testing

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 496
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07677891
What this trial is testing

Phase II Study of Switching From Dulaglutide to PG-102(MG12) in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
ProGen. Co., Ltd. 60
Large-scale testing (Phase 3)UnknownNCT02584582
What this trial is testing

The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate

Who this might be right for
Type 1 Diabetes
Hvidovre University Hospital 10
Not applicableStudy completedNCT07281196
What this trial is testing

Semaglutide Effects on Sleep Apnea in Patients With Type 2 Diabetes/Obesity and Comorbid Obstructive Sleep Apnea

Who this might be right for
Sleep Apnea Syndrome (OSAS)
Shanghai Fengxian District Central Hospital 15
Not applicableEnrolling By InvitationNCT07140289
What this trial is testing

Effect of Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) on Gastric Emptying

Who this might be right for
Gastric EmptyingGlucagon-Like Peptide-1 Receptor AgonistsIntermittent Fasting+2 more
Wael Saasouh, MD 100
Not applicableStudy completedNCT04337268
What this trial is testing

Acute Effects of GLP-1 on Renal Hemodynamics

Who this might be right for
The GLP-1-mediated Gut-kidney Axis
Rigshospitalet, Denmark 10
Post-approval studies (Phase 4)Ended earlyNCT01638260
What this trial is testing

GLP-1 and Non-exercise Activity Thermogenesis in RHZ

Who this might be right for
Type 2 Diabetes Mellitus
Maastricht University Medical Center 22
Early research (Phase 1)Study completedNCT02731664
What this trial is testing

GLP-1 Inhibits Prandial Antro-duodeno-jejunal Motility in Humans

Who this might be right for
Functional Gastrointestinal Disorders
Uppsala University 12
Not applicableStudy completedNCT01467063
What this trial is testing

Glutamine and Insulin Sensitivity in Type I Diabetes

Who this might be right for
Type I Diabetes Mellitus
Nemours Children's Clinic 13
Large-scale testing (Phase 3)Study completedNCT01676116
What this trial is testing

The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 438
Not applicableUnknownNCT03768518
What this trial is testing

GLP-1 Receptor Expression in CHI

Who this might be right for
Congenital Hyperinsulinism
Radboud University Medical Center 40
Not applicableNot Yet RecruitingNCT07723820
What this trial is testing

Glycemic Velocity and Early Retinal Microvascular Change With GLP-1RA Versus SGLT2i Initiation in Type 2 Diabetes (GLIDE)

Who this might be right for
Type 2 Diabetes MellitusDiabetic Retinopathy (DR)
Thammasat University Hospital 126
Not applicableActive Not RecruitingNCT07457424
What this trial is testing

Direct Measurement of Microstructure of Ingestive Behaviour After Initiation of GLP-1 Receptor Agonist Treatment at Maximum Dose (DIGRAT)

Who this might be right for
Metabolic DiseaseObesity & Overweight
University College Dublin 140
Next Page